Proposed Data Collections Submitted for Public Comment and Recommendations, 4852-4853 [05-1713]
Download as PDF
<![CDATA[
4852
Federal Register / Vol. 70, No. 19 / Monday, January 31, 2005 / Notices
1. Mohammad Mehdi Ghomeshi,
Miami, Florida; to acquire voting shares
of Great Financial Corporation, Miami
Lakes, Florida, and thereby indirectly
acquire voting shares of Great Florida
Bank, Miami, Florida.
Comments on this application must
be received by February 2, 2005.
Board of Governors of the Federal Reserve
System, January 25, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–1666 Filed 1–28–05; 8:45 am]
BILLING CODE 6210–01–S
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than February 25,
2005.
A. Federal Reserve Bank of Atlanta
(Andre Anderson, Vice President) 1000
Peachtree Street, N.E., Atlanta, Georgia
30303:
1. Community Bancshares of
Mississippi, Inc., Employee Stock
VerDate jul<14>2003
16:59 Jan 28, 2005
Jkt 205001
Ownership Plan, Brandon, Mississippi;
to become a bank holding company by
acquiring 58.6 percent of the voting
shares of the Community Bancshares of
Mississippi, Inc., Brandon, Mississippi;
and First National Bank of Lucedale,
Lucedale, Mississippi; Community Bank
of Mississippi, Forest, Mississippi;
Community Bank, Ellisville,
Mississippi, Ellisville, Mississippi;
Community Bank, Amory, Mississippi;
Community Bank, Indianola,
Mississippi, Indianola, Mississippi;
Community Bank, Coast, Biloxi,
Mississippi; Community Bank, Desoto
County, Southaven, Mississippi; and
Community Bank, Meridian,
Mississippi, Meridian, Mississippi.
2. Remo Duquoin LLC, Privee LLC,
and Privee Financial, Inc., all of Miami,
Florida; to acquire 100 percent of the
voting shares of Sequoia National Bank,
San Francisco, California.
Board of Governors of the Federal Reserve
System, January 25, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–1664 Filed 1–28–05; 8:45 am]
BILLING CODE 6210–01–S
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than February 15, 2005.
A. Federal Reserve Bank of St. Louis
(Randall C. Sumner, Vice President) 411
Locust Street, St. Louis, Missouri
63166–2034:
1. Community First Bancshares, Inc.,
Harrison, Arkansas; to retain voting
shares of Mobius Technology
Consulting, LLC, Springfield, Missouri,
and thereby engage in data processing
and management consulting activities,
pursuant to sections 225.28(b)(9)(i)(A)
and (b)(14)(i) respectively of Regulation
Y.
Board of Governors of the Federal Reserve
System, January 25, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–1665 Filed 1–28–05; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
FEDERAL RESERVE SYSTEM
[60Day–05AZ]
Notice of Proposals to Engage in
Permissible Nonbanking Activities or
to Acquire Companies that are
Engaged in Permissible Nonbanking
Activities
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y (12
CFR Part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act. Additional information on all
bank holding companies may be
obtained from the National Information
Center website at www.ffiec.gov/nic/.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5976 or send
comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
E:\FR\FM\31JAN1.SGM
31JAN1
Federal Register / Vol. 70, No. 19 / Monday, January 31, 2005 / Notices
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
A Library Of Participant Questions To
Be Used In Exposure Investigation
Questionnaires—New—The Agency for
Toxic Substances and Disease Registry
(ATSDR).
ATSDR is mandated pursuant to the
1980 Comprehensive Environmental
Response, Compensation, and Liability
Act (CERCLA) and its 1986
Amendments, the Superfund
Amendments and Reauthorization Act
(SARA) to prevent or mitigate adverse
human health effects and diminished
quality of life resulting from the
exposure to hazardous substances in the
environment. Exposure Investigations
are an approach developed by ATSDR
that employs targeted biologic and
environmental sampling to assist
ATSDR to better characterize past,
current, and possible future human
exposures to hazardous substances in
the environment. The purpose of
Exposure Investigations is to determine
in a timely manner whether community
residents are being exposed to chemical
contaminants at levels that might affect
their health. Exposure Investigations are
usually requested by officials of a state
health agency, county health
departments, the Environmental
Protection Agency, the general public,
and ATSDR staff.
During an Exposure Investigation
ATSDR conducts biomarker testing or
environmental testing or both.
Biomarkers may be sampled in urine,
blood, or hair. Environmental samples
(e.g., air, water, soil, or food) can be
taken from the environment where
people live, spend leisure time, or other
places they might come into contact
with contaminants under investigation.
In addition to the suspected
environmental exposure source being
investigated, additional exposure to the
contaminant may come from other
sources encountered in daily activities
such as jobs, hobbies, household
products, lifestyle, medicines, and
foods.
To assist in interpreting the sampling
results, a survey questionnaire
appropriate to the specific contaminant
will be administered to participants.
Only a limited number of questions
pertinent to exposure routes of the
contaminant of concern will be
administered in an investigation.
Questions will be asked about the
presence or absence of a specific
exposure and an estimate of its extent
and duration. Exposure to other sources
of the contaminant of concern will also
be queried in the survey. The
information gathered in the survey will
allow ATSDR to more accurately
interpret its testing results and
determine a likely source of elevated
biomarker tests.
Questionnaires will generally be
administered face-to-face and
4853
occasionally by phone or mail.
Typically, ATSDR conducts between
10–15 exposure investigations
nationally each year that would require
a questionnaire. The number of
participants per investigation ranges
from 10 to less than 50.
ATSDR is seeking approval for a set
of 40–43 potential questions. Of these,
approximately 12–15 questions about
the pertinent environmental pathways
in an Exposure Investigation will be
used. This number can vary depending
on the number of contaminants being
investigated, the route of exposure
(breathing, eating, touching), and a
number of other sources (e.g., products,
jobs) of the chemical(s). We will also
collect general information (e.g., name,
address,) necessary to conduct the
investigation; there are approximately
28 questions that will collect
demographic information. There are no
costs to respondents other than their
time.
Topic areas for the complete set of
questions include the following:
(1) Media specific which includes: air
(indoor/outdoor); water (water source
and plumbing); soil, and food
(gardening, fish, game, domestic
animals).
(2) Other sources such as: occupation;
hobbies; household uses or house
construction; lifestyle (e.g., smoking);
medicines and/or health conditions, and
foods.
Respondents
Number of
respondents
Number of
responses
per respondent
Average
burden
per response
in hours)
Total
burden
(in hours)
Exposure Investigation Participants ................................................................
750
1
30/60
375
........................
........................
........................
375
Total ..........................................................................................................
Dated: January 25, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of
the Chief Science Officer, Centers for Disease
Control and Prevention.
[FR Doc. 05–1713 Filed 1–28–05; 8:45 am]
[Docket No. 2004N–0441]
DATES:
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Application for
Food and Drug Administration
Approval to Market a New Drug
BILLING CODE 4163–18–P
Food and Drug Administration
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
ADDRESSES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
VerDate jul<14>2003
16:59 Jan 28, 2005
Jkt 205001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Fax written comments on the
collection of information by March 2,
2005.
OMB is still experiencing
significant delays in the regular mail,
including first class and express mail,
and messenger deliveries are not being
accepted. To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: Fumie Yokota, Desk Officer
for FDA, FAX: 202–395–6974.
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 70, Number 19 (Monday, January 31, 2005)]
[Notices]
[Pages 4852-4853]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-1713]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05AZ]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-371-5976 or
send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an email
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques
[[Page 4853]]
or other forms of information technology. Written comments should be
received within 60 days of this notice.
Proposed Project
A Library Of Participant Questions To Be Used In Exposure
Investigation Questionnaires--New--The Agency for Toxic Substances and
Disease Registry (ATSDR).
ATSDR is mandated pursuant to the 1980 Comprehensive Environmental
Response, Compensation, and Liability Act (CERCLA) and its 1986
Amendments, the Superfund Amendments and Reauthorization Act (SARA) to
prevent or mitigate adverse human health effects and diminished quality
of life resulting from the exposure to hazardous substances in the
environment. Exposure Investigations are an approach developed by ATSDR
that employs targeted biologic and environmental sampling to assist
ATSDR to better characterize past, current, and possible future human
exposures to hazardous substances in the environment. The purpose of
Exposure Investigations is to determine in a timely manner whether
community residents are being exposed to chemical contaminants at
levels that might affect their health. Exposure Investigations are
usually requested by officials of a state health agency, county health
departments, the Environmental Protection Agency, the general public,
and ATSDR staff.
During an Exposure Investigation ATSDR conducts biomarker testing
or environmental testing or both. Biomarkers may be sampled in urine,
blood, or hair. Environmental samples (e.g., air, water, soil, or food)
can be taken from the environment where people live, spend leisure
time, or other places they might come into contact with contaminants
under investigation. In addition to the suspected environmental
exposure source being investigated, additional exposure to the
contaminant may come from other sources encountered in daily activities
such as jobs, hobbies, household products, lifestyle, medicines, and
foods.
To assist in interpreting the sampling results, a survey
questionnaire appropriate to the specific contaminant will be
administered to participants. Only a limited number of questions
pertinent to exposure routes of the contaminant of concern will be
administered in an investigation. Questions will be asked about the
presence or absence of a specific exposure and an estimate of its
extent and duration. Exposure to other sources of the contaminant of
concern will also be queried in the survey. The information gathered in
the survey will allow ATSDR to more accurately interpret its testing
results and determine a likely source of elevated biomarker tests.
Questionnaires will generally be administered face-to-face and
occasionally by phone or mail. Typically, ATSDR conducts between 10-15
exposure investigations nationally each year that would require a
questionnaire. The number of participants per investigation ranges from
10 to less than 50.
ATSDR is seeking approval for a set of 40-43 potential questions.
Of these, approximately 12-15 questions about the pertinent
environmental pathways in an Exposure Investigation will be used. This
number can vary depending on the number of contaminants being
investigated, the route of exposure (breathing, eating, touching), and
a number of other sources (e.g., products, jobs) of the chemical(s). We
will also collect general information (e.g., name, address,) necessary
to conduct the investigation; there are approximately 28 questions that
will collect demographic information. There are no costs to respondents
other than their time.
Topic areas for the complete set of questions include the
following:
(1) Media specific which includes: air (indoor/outdoor); water
(water source and plumbing); soil, and food (gardening, fish, game,
domestic animals).
(2) Other sources such as: occupation; hobbies; household uses or
house construction; lifestyle (e.g., smoking); medicines and/or health
conditions, and foods.
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Exposure Investigation Participants......... 750 1 30/60 375
------------------
Total................................... ............... ............... ............... 375
----------------------------------------------------------------------------------------------------------------
Dated: January 25, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of the Chief Science Officer,
Centers for Disease Control and Prevention.
[FR Doc. 05-1713 Filed 1-28-05; 8:45 am]
BILLING CODE 4163-18-P
